COVID-19 Vaccination AZV 2021-2023
NCT05589233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2023-12-08
Summary
The study is aimed at the clinical and laboratory characteristics of patients with completed vaccination against SARS-CoV-2 admitted to the hospital in the standard ward and intensive care unit due to the severe course of COVID-19.
Conditions
- COVID-19
- Vaccination
- Immunity
- Respiratory Failure
Interventions
- BIOLOGICAL
-
Vaccionation eighter started or full course
Vaccination against SARS-CoV-2 at any number of doses
Sponsors & Collaborators
-
University Hospital Hradec Kralove
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2023-11-30
- Completion
- 2023-11-30
Countries
- Czechia
Study Locations
More Related Trials
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
NCT04537663 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination
NCT04417335 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)
NCT05244330 ·Status: COMPLETED
-
Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
NCT04332094 ·Status: UNKNOWN ·Phase: PHASE2
-
Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
NCT06334731 ·Status: COMPLETED
-
Evaluation of Antibody Tests for COVID-19
NCT04360954 ·Status: COMPLETED
-
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers
NCT04461379 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
NCT07029932 ·Status: RECRUITING ·Phase: PHASE1
-
Long COVID in Military Organisations
NCT04942249 ·Status: UNKNOWN
-
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
NCT05942820 ·Status: TERMINATED ·Phase: PHASE1
-
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
NCT01212601 ·Status: COMPLETED
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
Bacteriophage Therapy of Difficult-to-treat Infections
NCT05498363 ·Status: COMPLETED
-
Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19
NCT04716088 ·Status: COMPLETED
-
Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19
NCT04350931 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.
NCT06057025 ·Status: UNKNOWN ·Phase: PHASE3
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
NCT05422963 ·Status: UNKNOWN
-
Dysbiosis & Long COVID
NCT06825819 ·Status: RECRUITING
-
Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
NCT04648800 ·Status: UNKNOWN ·Phase: PHASE3
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3